Stay informed with Symbiosis’ latest news and updates. Explore our company advancements, industry developments, and key business milestones aimed to support your biopharmaceutical manufacturing projects.
31 March 2020
Colin MacKay, CEO of Symbiosis Pharmaceutical Services, recently took part in a Q&A interview with BioPharma-Reporter, discussing how increased manufacturing...
13 May 2019
London, UK – Freeline, a biotechnology company focused on developing curative gene therapies for chronic systemic diseases, has secured a...
24 September 2018
Stirling, UK – SYMBIOSIS Pharmaceutical Services, a fast-growing specialist sterile manufacturing CDMO, has reported FDA approval for its viral vector...
1 February 2018
Keele and Stirling, UK, 1 February 2018: Cobra Biologics (Cobra), an international contract development and manufacturing organisation (CDMO) of biologics...
13 February 2017
Symbiosis Pharmaceutical Services is set to open an office in North America in response to continued demand from US-based biotechnology...
21 May 2015
Stirling, UK – STERILE manufacturing specialist Symbiosis Pharmaceutical Services has unveiled a new bulk lyophilisation (freeze drying) service after winning...
17 December 2014
UK-based sterile filling specialist Symbiosis Pharmaceutical Services has strengthened its North American footprint with the appointment of a US-based business...
5 July 2013
Symbiosis successfully completes the full qualification of its two sterile fill/finish and lyophilisation cleanroom suites. Symbiosis is delighted to announce...
1 February 2013
Leading on from the receipt of our Investigational Medicinal Products (IMP-MA) manufacturing licence from the UK Government regulator, the MHRA,...
1 October 2012
Symbiosis Pharmaceutical Services Limited, an MHRA-approved sterile manufacturing facility based in Stirling, Scotland is an exciting, young company specializing in...
